XML 49 R40.htm IDEA: XBRL DOCUMENT v3.22.0.1
Share-based Compensation (Tables)
6 Months Ended
Dec. 31, 2021
Share-based Compensation  
Schedule of weighted average assumptions

​

​

​

​

​

​

​

​

Six Months Ended

​

​

December 31, 2020

Risk-free interest rate

​

​

0.2

%

Expected volatility

​

​

82.5

%

Expected dividend yield

​

​

—

%

Forfeiture rate

​

​

—

%

Expected term

​

​

5.0

years

Weighted average fair value

​

$

3.86

​

Summary of stock option award activity

​

​

​

​

​

​

​

​

​

​

​

​

​

    

    

    

​

​

    

​

​

    

Weighted

​

​

​

​

Weighted-

​

​

​

​

Average

​

​

​

​

Average

​

Aggregate

​

Remaining

​

​

​

​

Exercise

​

Intrinsic

​

Contractual

(In thousands, except for weighted average price and life data)

    

Awards

    

Price

    

Value

    

Life (yrs.)

Outstanding at June 30, 2021

 

1,046

​

$ 

9.51

​

$

25

​

7.2

Exercised

 

(3)

​

$ 

3.55

​

$

2

​

​

Forfeited, expired or repurchased

 

(11)

​

$ 

7.62

​

​

​

​

​

Outstanding at December 31, 2021

 

1,032

​

$ 

9.55

​

$

—

​

6.8

​

​

​

​

​

​

​

​

​

​

​

Vested and expected to vest at December 31, 2021

 

1,032

​

$ 

9.55

​

$

—

​

6.8

Exercisable at December 31, 2021

 

626

​

$ 

11.67

​

$

—

​

5.9

​

Summary of non-vested restricted stock awards

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Weighted

​

​

​

​

​

​

​

Average Grant -

​

Aggregate

(In thousands, except for weighted average price data)

    

Awards

    

date Fair Value

    

Intrinsic Value

Non-vested at June 30, 2021

 

1,350

​

$

6.75

​

​

​

Granted

 

1,110

​

 

4.14

​

​

​

Vested

 

(973)

​

 

5.98

​

$

3,765

Forfeited

 

(83)

​

 

5.72

​

​

​

Non-vested at December 31, 2021

 

1,404

​

$

5.28

​

​

​

​

Schedule of non-vested performance-based shares

​

​

​

​

​

​

​

​

​

​

​

​

Weighted

​

​

​

​

​

Average Grant -

​

(In thousands, except for weighted average price and life data)

    

Awards

    

date Fair Value

    

Non-vested at June 30, 2021

 

531

​

$

10.29

​

Granted

 

617

​

$

6.04

​

Performance adjustment (1)

​

(40)

​

$

17.69

​

Vested

 

(58)

​

$

7.72

​

Non-vested at December 31, 2021

 

1,050

​

$

7.65

​

(1)Represents the adjustment based on the performance of the July 2018 awards, which was below the Threshold goal level at the end of the three-year performance period.
Schedule of allocation of share-based compensation

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Three Months Ended

​

Six Months Ended

​

​

​

December 31, 

​

December 31, 

​

(In thousands)

    

2021

    

2020

    

2021

    

2020

​

Selling, general and administrative expenses

​

$

2,115

​

$

1,507

​

$

4,812

​

$

4,221

​

Research and development expenses

​

 

27

​

 

132

​

 

122

​

 

287

​

Cost of sales

​

 

167

​

 

352

​

 

393

​

 

825

​

Total

​

$

2,309

​

$

1,991

​

$

5,327

​

$

5,333

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Tax benefit at statutory rate

​

$

519

​

$

448

​

$

1,199

​

$

1,200

​